Zimmer Biomet (ZBH) PT Raised to $197 at Baird
Tweet Send to a Friend
Baird analyst Jeffrey Johnson raised the price target on Zimmer Biomet (NYSE: ZBH) to $197.00 (from $195.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


